Birgitta-A
Mon Jan 14, 2008, 01:48 PM
Hi all,
It is almost four years since Vidaza was approved by FDA. Now it will probably be approved in Europe. January 14, 2008 Pharmion submitted European marketing authorization application for Vidaza in patients with higher-risk myelodysplastic syndromes :).
Kind regards
Birgitta
68 yo, MDS Interm-1 dx May 2006, transfusion dependent, Desferal 4 days with transfusion every 6yh week, Neupogen 2 injections/week
It is almost four years since Vidaza was approved by FDA. Now it will probably be approved in Europe. January 14, 2008 Pharmion submitted European marketing authorization application for Vidaza in patients with higher-risk myelodysplastic syndromes :).
Kind regards
Birgitta
68 yo, MDS Interm-1 dx May 2006, transfusion dependent, Desferal 4 days with transfusion every 6yh week, Neupogen 2 injections/week